Design, synthesis, and biological evaluation of potent c-Met inhibitors.
D'Angelo, N.D., Bellon, S.F., Booker, S.K., Cheng, Y., Coxon, A., Dominguez, C., Fellows, I., Hoffman, D., Hungate, R., Kaplan-Lefko, P., Lee, M.R., Li, C., Liu, L., Rainbeau, E., Reider, P.J., Rex, K., Siegmund, A., Sun, Y., Tasker, A.S., Xi, N., Xu, S., Yang, Y., Zhang, Y., Burgess, T.L., Dussault, I., Kim, T.S.(2008) J Med Chem 51: 5766-5779
- PubMed: 18763753 
- DOI: 10.1021/jm8006189
- Primary Citation of Related Structures:  
3EFJ, 3EFK - PubMed Abstract: 
c-Met is a receptor tyrosine kinase that plays a key role in several cellular processes but has also been found to be overexpressed and mutated in different human cancers. Consequently, targeting this enzyme has become an area of intense research in drug discovery ...